Previous close | 4.7100 |
Open | 4.8200 |
Bid | 0.0000 x 0 |
Ask | 4.7800 x 100 |
Day's range | 4.5000 - 4.8200 |
52-week range | 4.2200 - 20.1900 |
Volume | |
Avg. volume | 41,562 |
Market cap | 164.618M |
Beta (5Y monthly) | 0.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of 5% and 51.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Orchestra BioMed Holdings ( NASDAQ:OBIO ) Full Year 2023 Results Key Financial Results Net loss: US$49.1m (loss widened...
Orchestra BioMed (OBIO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.